Colorectal cancer in France

  • Karine ChevreulEmail author
Original Paper


Colorectal cancer (CRC) presents a substantial health burden in France, as the third cause of new cancer cases after breast and prostate cancers and the second cancer mortality cause representing nearly 12% of cancer deaths and almost 10% of annual life year loss due to cancer. Its prognosis has dramatically improved since the 1970s due to earlier diagnosis and an increase in the number of cases eligible for surgery. The first cancer plan implemented for the period 2003–2006 led to further improvements via, amongst others, implementing a national cancer institute (INCA), developing research, improving the quality of care and facilitating access to innovative treatments. The second cancer plan (2009–2013) aims to expand the scope of the existing cancer plan including improving primary and secondary prevention. Indeed, CRC national screening was recently implemented across France, however, the rate of the target population actually screened remains low while earlier detection of CRC at early stages should lead to an increase in France’s CRC survival rates.


Colorectal cancer France Cancer plan Treatment Cost 

JEL Classification

I11 I12 I18 


Conflict of interest statement

The author does not report any conflict of interest associated with this paper.


  1. 1.
  2. 2.
    Paris, V.: The cancer plan—2003–2007. Health Policy Monitor. (2004)
  3. 3.
  4. 4.
    Grunfeld, J.P. (ed.): Recommendations pour le plan cancer: pour un nouvel élan, rapport au Président de la République. (2009)
  5. 5.
    Amalric, F.: Analyse économique du coût du cancer en France, INCA., p. 146 (2007)
  6. 6.
    Bouvier, A.M.: Epidemiologie descriptive du cancer colorectal en France, bulletin d’épidémiologie hébdomadaire, INVS, n 2–3. (2009)
  7. 7.
    Faivre, J., Dancourt, V., Lejeune, C., et al.: Reduction in colorectal mortality by faecal occult blood screening in a French controlled study. Gastroenterology 126, 1674–1680 (2004)CrossRefGoogle Scholar
  8. 8.
    Goulard, H., Boussac-Zarebska, M., Ancelle-Park, R., et al.: French colorectal cancer screening pilot programme: results of the first round. J. Med. Screen. 15, 143–148 (2008)CrossRefGoogle Scholar
  9. 9.
    Faivre, J., Lepage, C., Dancourt, V.: Le dépistage organisé du cancer colorectal en France et en Europe: historique et état des lieux, bulletin d’épidémiologie hébdomadaire, INVS, n 2–3. (2009)
  10. 10.
    Rivera, P., Delord, J.P., Grosclaude, P., et al.: Démographie des oncologues praticiens en exercice en France, éléments de projection pour les trente prochaines années. Bulletin de Cancerologie 91, 271–277 (2004)Google Scholar
  11. 11.
    Afrite, A., Chaleix, M., Com-ruelle, L., et al.: L’hospitalisation à domicile, une prise en charge qui s’adresse à tous les patients. Questions d’économie de la santé 140, IRDES. (2009)
  12. 12.
    Com-ruelle, L., Lucas, G.V., Renaud, T.: Le coût du cancer du colon en Ile de France, Question d’économie de la santé, 98, Irdes. (2005)
  13. 13.
    Clerc, L., Jooste, V., Lejeune, C., et al.: Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur. J. Health Econ. 9, 361–367 (2005)CrossRefGoogle Scholar
  14. 14.
    Coleman, M.P., Quaresma, M., Berrino, F., et al.: Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 9, 730–756 (2008)CrossRefGoogle Scholar
  15. 15.
    National Institute of Cancer. Clinical guidelines for good practice, DRG tariffs for digestive cancers, January 2007 revised December 2008 and May 2009, pp. 86 ( Accessed Aug 2009

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Paris Health Economics and Health Services Research Unit, AP-HP, LIC EA 4393University Paris 12ParisFrance

Personalised recommendations